Definitive Healthcare Past Earnings Performance
Past criteria checks 0/6
Definitive Healthcare's earnings have been declining at an average annual rate of -81.6%, while the Healthcare Services industry saw earnings growing at 23.3% annually. Revenues have been growing at an average rate of 20.7% per year.
Key information
-81.6%
Earnings growth rate
-70.0%
EPS growth rate
| Healthcare Services Industry Growth | 1.7% |
| Revenue growth rate | 20.7% |
| Return on equity | -74.8% |
| Net Margin | -142.4% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Definitive Healthcare: Poor Near-Term Outlook, But New CEO May Change Things
Aug 19More Unpleasant Surprises Could Be In Store For Definitive Healthcare Corp.'s (NASDAQ:DH) Shares After Tumbling 28%
Aug 01
Definitive Healthcare: Weak Near-Term Growth To Put Valuation In Rangebound
Jun 25Risks Still Elevated At These Prices As Definitive Healthcare Corp. (NASDAQ:DH) Shares Dive 26%
May 30Pinning Down Definitive Healthcare Corp.'s (NASDAQ:DH) P/S Is Difficult Right Now
Apr 14Definitive Healthcare: Reiterate Buy Rating As I Expect Growth To Recover In FY25
Mar 19Is Definitive Healthcare (NASDAQ:DH) Using Debt In A Risky Way?
Feb 16An Intrinsic Calculation For Definitive Healthcare Corp. (NASDAQ:DH) Suggests It's 42% Undervalued
Dec 29Definitive Healthcare Corp. (NASDAQ:DH) Stock Rockets 31% As Investors Are Less Pessimistic Than Expected
Nov 24Estimating The Fair Value Of Definitive Healthcare Corp. (NASDAQ:DH)
Jun 02Definitive Healthcare Corp. (NASDAQ:DH) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
May 06A Look At The Fair Value Of Definitive Healthcare Corp. (NASDAQ:DH)
Dec 08Definitive Healthcare Grows Headcount Despite Gathering Recession Clouds
Aug 31Definitive Healthcare Corp.'s (NASDAQ:DH) Intrinsic Value Is Potentially 27% Above Its Share Price
Jul 17Definitive Healthcare: No Involvement Yet Here
Jun 05Revenue & Expenses Breakdown
How Definitive Healthcare makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 256 | -364 | 144 | 39 |
| 30 Jun 24 | 258 | -405 | 150 | 43 |
| 31 Mar 24 | 256 | -200 | 155 | 43 |
| 31 Dec 23 | 251 | -202 | 153 | 42 |
| 30 Sep 23 | 246 | -182 | 153 | 41 |
| 30 Jun 23 | 238 | -14 | 151 | 39 |
| 31 Mar 23 | 232 | -11 | 146 | 38 |
| 31 Dec 22 | 223 | -7 | 141 | 35 |
| 30 Sep 22 | 208 | -27 | 133 | 31 |
| 30 Jun 22 | 194 | -32 | 120 | 26 |
| 31 Mar 22 | 179 | -16 | 105 | 22 |
| 31 Dec 21 | 166 | -18 | 89 | 19 |
| 30 Sep 21 | 153 | -8 | 74 | 16 |
| 30 Jun 21 | 140 | 0 | 62 | 14 |
| 31 Mar 21 | 128 | 2 | 53 | 12 |
| 31 Dec 20 | 118 | 0 | 49 | 11 |
| 31 Dec 19 | 86 | -36 | 37 | 7 |
Quality Earnings: DH is currently unprofitable.
Growing Profit Margin: DH is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: DH is unprofitable, and losses have increased over the past 5 years at a rate of 81.6% per year.
Accelerating Growth: Unable to compare DH's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: DH is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (17.5%).
Return on Equity
High ROE: DH has a negative Return on Equity (-74.77%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 10:58 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Definitive Healthcare Corp. is covered by 19 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Joseph Vruwink | Baird |
| Saket Kalia | Barclays |
| Allen Lutz | BofA Global Research |